Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines
Background: Allergen immunotherapy (AIT) has a longstanding history and still remains the only disease-changing treatment for allergic rhinitis and asthma. Over the years 2 different schools have developed their strategies: the United States (US) and the European. Allergen extracts available in thes...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | inglés |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | http://eprints.uanl.mx/20100/1/1-s2.0-S1939455120303471-main.pdf |
| _version_ | 1824415749296357376 |
|---|---|
| author | Larenas Linnemann, Désirée Rodríguez Pérez, Noel Luna Pech, Jorge A. Rodríguez González, Mónica Blandón Vijil, María Virginia Del Río Navarro, Blanca E. Costa Domínguez, María del Carmen Navarrete Rodríguez, Elsy Maureen Macouzet Sánchez, Carlos Ortega Martell, José Antonio Pozo Beltrán, César Fireth Estrada Cardona, Alan Arias Cruz, Alfredo Rodríguez Galván, Karen Guadalupe Brito Díaz, Herson Canseco Raymundo, María Del Rosario Castelán Chávez, Enrique Emanuel Escalante Domínguez, Alberto José Gálvez Romero, José Luis Gómez Vera, Javier González Díaz, Sandra Nora Guerrero Núñez, María Gracia Belinda Hernández Colín, Dante Daniel Macías Weinmann, Alejandra Mendoza Hernández, David Alejandro Meneses Sánchez, Néstor Alejandro Mogica Martínez, María Dolores Moncayo Coello, Carol Vivian Montiel Herrera, Juan Manuel O'Farril Romanillos, Patricia María Onuma Takane, Ernesto Ortega Cisneros, Margarita Rangel Garza, Lorena Stone Aguilar, Héctor Torres Lozano, Carlos Venegas Montoya, Edna Wakida Kusunoki, Guillermo Partida Gaytán, Armando López García, Aída Inés Macías Robles, Ana Paola Ambriz Moreno, María de Jesús Azamar Jácome, Amyra Ali Beltrán de Paz, Claudia Yusdivia Caballero López, Chrystopherson Fernández de Córdova Aguirre, Juan Carlos Fernández Soto, José Roberto Lozano Sáenz, José Santos Oyoqui Flores, José Joel Osorio Escamilla, Roberto Efrain Ramírez Jiménez, Fernando Rivero Yeverino, Daniela Martínez Infante, Eric Medina Ávalos, Miguel Alejandro |
| author_facet | Larenas Linnemann, Désirée Rodríguez Pérez, Noel Luna Pech, Jorge A. Rodríguez González, Mónica Blandón Vijil, María Virginia Del Río Navarro, Blanca E. Costa Domínguez, María del Carmen Navarrete Rodríguez, Elsy Maureen Macouzet Sánchez, Carlos Ortega Martell, José Antonio Pozo Beltrán, César Fireth Estrada Cardona, Alan Arias Cruz, Alfredo Rodríguez Galván, Karen Guadalupe Brito Díaz, Herson Canseco Raymundo, María Del Rosario Castelán Chávez, Enrique Emanuel Escalante Domínguez, Alberto José Gálvez Romero, José Luis Gómez Vera, Javier González Díaz, Sandra Nora Guerrero Núñez, María Gracia Belinda Hernández Colín, Dante Daniel Macías Weinmann, Alejandra Mendoza Hernández, David Alejandro Meneses Sánchez, Néstor Alejandro Mogica Martínez, María Dolores Moncayo Coello, Carol Vivian Montiel Herrera, Juan Manuel O'Farril Romanillos, Patricia María Onuma Takane, Ernesto Ortega Cisneros, Margarita Rangel Garza, Lorena Stone Aguilar, Héctor Torres Lozano, Carlos Venegas Montoya, Edna Wakida Kusunoki, Guillermo Partida Gaytán, Armando López García, Aída Inés Macías Robles, Ana Paola Ambriz Moreno, María de Jesús Azamar Jácome, Amyra Ali Beltrán de Paz, Claudia Yusdivia Caballero López, Chrystopherson Fernández de Córdova Aguirre, Juan Carlos Fernández Soto, José Roberto Lozano Sáenz, José Santos Oyoqui Flores, José Joel Osorio Escamilla, Roberto Efrain Ramírez Jiménez, Fernando Rivero Yeverino, Daniela Martínez Infante, Eric Medina Ávalos, Miguel Alejandro |
| author_sort | Larenas Linnemann, Désirée |
| collection | Repositorio Institucional |
| description | Background: Allergen immunotherapy (AIT) has a longstanding history and still remains the only disease-changing treatment for allergic rhinitis and asthma. Over the years 2 different schools have developed their strategies: the United States (US) and the European. Allergen extracts available in these regions are adapted to local practice. In other parts of the world, extracts from both regions
and local ones are commercialized, as in Mexico. Here, local experts developed a national AIT guideline (GUIMIT 2019) searching for compromises between both schools.
Methods: Using ADAPTE methodology for transculturizing guidelines and AGREE-II for evaluating guideline quality, GUIMIT selected 3 high-quality Main Reference Guidelines (MRGs): the European Academy of Allergy, Asthma and Immunology (EAACI) guideines, the S2k guideline of
various German-speaking medical societies (2014), and the US Practice Parameters on Allergen Immunotherapy 2011. We formulated clinical questions and based responses on the fused evidence available in the MRGs, combined with local possibilities, patient's preference, and costs. We
came across several issues on which the MRGs disagreed. These are presented here along with arguments of GUIMIT members to resolve them. GUIMIT (for a complete English version, see Supplementary data) concluded the following:
Results: Related to the diagnosis of IgE-mediated respiratory allergy, apart from skin prick testing
complementary tests (challenges, in vitro testing and molecular such as species-specific allergens) might be useful in selected cases to inform AIT composition. AIT is indicated in allergic rhinitis and suggested in allergic asthma (once controlled) and IgE-mediated atopic dermatitis. Concerning the correct subcutaneous AIT dose for compounding vials according to the US school: dosing tables and formula are given; up to 4 non-related allergens can be mixed, refraining from mixing high with low protease extracts. When using European extracts: the manufacturer's indications
should be followed; in multi-allergic patients 2 simultaneous injections can be given (100% consensus); mixing is discouraged. In Mexico only allergoid tablets are available; based on doses used in all sublingual immunotherapy (SLIT) publications referenced in MRGs, GUIMIT suggests a probable effective dose related to subcutaneous immunotherapy (SCIT) might be: 50–200% of the monthly SCIT dose given daily, maximum mixing 4 allergens. Also, a table with practical suggestions on non-evidence-existing issues, developed with a simplified Delphi method, is added.
Finally, dissemination and implementation of guidelines is briefly discussed, explaining how we used online tools for this in Mexico.
Conclusions: Countries where European and American AIT extracts are available should adjust AIT according to which school is followed. |
| format | Article |
| id | eprints-20100 |
| institution | UANL |
| language | English |
| publishDate | 2020 |
| record_format | eprints |
| spelling | eprints-201002022-03-14T21:53:05Z http://eprints.uanl.mx/20100/ Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines Larenas Linnemann, Désirée Rodríguez Pérez, Noel Luna Pech, Jorge A. Rodríguez González, Mónica Blandón Vijil, María Virginia Del Río Navarro, Blanca E. Costa Domínguez, María del Carmen Navarrete Rodríguez, Elsy Maureen Macouzet Sánchez, Carlos Ortega Martell, José Antonio Pozo Beltrán, César Fireth Estrada Cardona, Alan Arias Cruz, Alfredo Rodríguez Galván, Karen Guadalupe Brito Díaz, Herson Canseco Raymundo, María Del Rosario Castelán Chávez, Enrique Emanuel Escalante Domínguez, Alberto José Gálvez Romero, José Luis Gómez Vera, Javier González Díaz, Sandra Nora Guerrero Núñez, María Gracia Belinda Hernández Colín, Dante Daniel Macías Weinmann, Alejandra Mendoza Hernández, David Alejandro Meneses Sánchez, Néstor Alejandro Mogica Martínez, María Dolores Moncayo Coello, Carol Vivian Montiel Herrera, Juan Manuel O'Farril Romanillos, Patricia María Onuma Takane, Ernesto Ortega Cisneros, Margarita Rangel Garza, Lorena Stone Aguilar, Héctor Torres Lozano, Carlos Venegas Montoya, Edna Wakida Kusunoki, Guillermo Partida Gaytán, Armando López García, Aída Inés Macías Robles, Ana Paola Ambriz Moreno, María de Jesús Azamar Jácome, Amyra Ali Beltrán de Paz, Claudia Yusdivia Caballero López, Chrystopherson Fernández de Córdova Aguirre, Juan Carlos Fernández Soto, José Roberto Lozano Sáenz, José Santos Oyoqui Flores, José Joel Osorio Escamilla, Roberto Efrain Ramírez Jiménez, Fernando Rivero Yeverino, Daniela Martínez Infante, Eric Medina Ávalos, Miguel Alejandro RC Medicina Interna, Psiquiatría, Neurología Background: Allergen immunotherapy (AIT) has a longstanding history and still remains the only disease-changing treatment for allergic rhinitis and asthma. Over the years 2 different schools have developed their strategies: the United States (US) and the European. Allergen extracts available in these regions are adapted to local practice. In other parts of the world, extracts from both regions and local ones are commercialized, as in Mexico. Here, local experts developed a national AIT guideline (GUIMIT 2019) searching for compromises between both schools. Methods: Using ADAPTE methodology for transculturizing guidelines and AGREE-II for evaluating guideline quality, GUIMIT selected 3 high-quality Main Reference Guidelines (MRGs): the European Academy of Allergy, Asthma and Immunology (EAACI) guideines, the S2k guideline of various German-speaking medical societies (2014), and the US Practice Parameters on Allergen Immunotherapy 2011. We formulated clinical questions and based responses on the fused evidence available in the MRGs, combined with local possibilities, patient's preference, and costs. We came across several issues on which the MRGs disagreed. These are presented here along with arguments of GUIMIT members to resolve them. GUIMIT (for a complete English version, see Supplementary data) concluded the following: Results: Related to the diagnosis of IgE-mediated respiratory allergy, apart from skin prick testing complementary tests (challenges, in vitro testing and molecular such as species-specific allergens) might be useful in selected cases to inform AIT composition. AIT is indicated in allergic rhinitis and suggested in allergic asthma (once controlled) and IgE-mediated atopic dermatitis. Concerning the correct subcutaneous AIT dose for compounding vials according to the US school: dosing tables and formula are given; up to 4 non-related allergens can be mixed, refraining from mixing high with low protease extracts. When using European extracts: the manufacturer's indications should be followed; in multi-allergic patients 2 simultaneous injections can be given (100% consensus); mixing is discouraged. In Mexico only allergoid tablets are available; based on doses used in all sublingual immunotherapy (SLIT) publications referenced in MRGs, GUIMIT suggests a probable effective dose related to subcutaneous immunotherapy (SCIT) might be: 50–200% of the monthly SCIT dose given daily, maximum mixing 4 allergens. Also, a table with practical suggestions on non-evidence-existing issues, developed with a simplified Delphi method, is added. Finally, dissemination and implementation of guidelines is briefly discussed, explaining how we used online tools for this in Mexico. Conclusions: Countries where European and American AIT extracts are available should adjust AIT according to which school is followed. 2020 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/20100/1/1-s2.0-S1939455120303471-main.pdf http://eprints.uanl.mx/20100/1.haspreviewThumbnailVersion/1-s2.0-S1939455120303471-main.pdf Larenas Linnemann, Désirée y Rodríguez Pérez, Noel y Luna Pech, Jorge A. y Rodríguez González, Mónica y Blandón Vijil, María Virginia y Del Río Navarro, Blanca E. y Costa Domínguez, María del Carmen y Navarrete Rodríguez, Elsy Maureen y Macouzet Sánchez, Carlos y Ortega Martell, José Antonio y Pozo Beltrán, César Fireth y Estrada Cardona, Alan y Arias Cruz, Alfredo y Rodríguez Galván, Karen Guadalupe y Brito Díaz, Herson y Canseco Raymundo, María Del Rosario y Castelán Chávez, Enrique Emanuel y Escalante Domínguez, Alberto José y Gálvez Romero, José Luis y Gómez Vera, Javier y González Díaz, Sandra Nora y Guerrero Núñez, María Gracia Belinda y Hernández Colín, Dante Daniel y Macías Weinmann, Alejandra y Mendoza Hernández, David Alejandro y Meneses Sánchez, Néstor Alejandro y Mogica Martínez, María Dolores y Moncayo Coello, Carol Vivian y Montiel Herrera, Juan Manuel y O'Farril Romanillos, Patricia María y Onuma Takane, Ernesto y Ortega Cisneros, Margarita y Rangel Garza, Lorena y Stone Aguilar, Héctor y Torres Lozano, Carlos y Venegas Montoya, Edna y Wakida Kusunoki, Guillermo y Partida Gaytán, Armando y López García, Aída Inés y Macías Robles, Ana Paola y Ambriz Moreno, María de Jesús y Azamar Jácome, Amyra Ali y Beltrán de Paz, Claudia Yusdivia y Caballero López, Chrystopherson y Fernández de Córdova Aguirre, Juan Carlos y Fernández Soto, José Roberto y Lozano Sáenz, José Santos y Oyoqui Flores, José Joel y Osorio Escamilla, Roberto Efrain y Ramírez Jiménez, Fernando y Rivero Yeverino, Daniela y Martínez Infante, Eric y Medina Ávalos, Miguel Alejandro (2020) Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines. World Allergy Organization Journal, 13 (8). p. 100444. ISSN 1939-4551 http://doi.org/10.1016/J.WAOJOU.2020.100444 doi:10.1016/J.WAOJOU.2020.100444 |
| spellingShingle | RC Medicina Interna, Psiquiatría, Neurología Larenas Linnemann, Désirée Rodríguez Pérez, Noel Luna Pech, Jorge A. Rodríguez González, Mónica Blandón Vijil, María Virginia Del Río Navarro, Blanca E. Costa Domínguez, María del Carmen Navarrete Rodríguez, Elsy Maureen Macouzet Sánchez, Carlos Ortega Martell, José Antonio Pozo Beltrán, César Fireth Estrada Cardona, Alan Arias Cruz, Alfredo Rodríguez Galván, Karen Guadalupe Brito Díaz, Herson Canseco Raymundo, María Del Rosario Castelán Chávez, Enrique Emanuel Escalante Domínguez, Alberto José Gálvez Romero, José Luis Gómez Vera, Javier González Díaz, Sandra Nora Guerrero Núñez, María Gracia Belinda Hernández Colín, Dante Daniel Macías Weinmann, Alejandra Mendoza Hernández, David Alejandro Meneses Sánchez, Néstor Alejandro Mogica Martínez, María Dolores Moncayo Coello, Carol Vivian Montiel Herrera, Juan Manuel O'Farril Romanillos, Patricia María Onuma Takane, Ernesto Ortega Cisneros, Margarita Rangel Garza, Lorena Stone Aguilar, Héctor Torres Lozano, Carlos Venegas Montoya, Edna Wakida Kusunoki, Guillermo Partida Gaytán, Armando López García, Aída Inés Macías Robles, Ana Paola Ambriz Moreno, María de Jesús Azamar Jácome, Amyra Ali Beltrán de Paz, Claudia Yusdivia Caballero López, Chrystopherson Fernández de Córdova Aguirre, Juan Carlos Fernández Soto, José Roberto Lozano Sáenz, José Santos Oyoqui Flores, José Joel Osorio Escamilla, Roberto Efrain Ramírez Jiménez, Fernando Rivero Yeverino, Daniela Martínez Infante, Eric Medina Ávalos, Miguel Alejandro Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines |
| thumbnail | https://rediab.uanl.mx/themes/sandal5/images/online.png |
| title | Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines |
| title_full | Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines |
| title_fullStr | Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines |
| title_full_unstemmed | Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines |
| title_short | Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines |
| title_sort | compromising between european and us allergen immunotherapy schools discussions from guimit the mexican immunotherapy guidelines |
| topic | RC Medicina Interna, Psiquiatría, Neurología |
| url | http://eprints.uanl.mx/20100/1/1-s2.0-S1939455120303471-main.pdf |
| work_keys_str_mv | AT larenaslinnemanndesiree compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT rodriguezpereznoel compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT lunapechjorgea compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT rodriguezgonzalezmonica compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT blandonvijilmariavirginia compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT delrionavarroblancae compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT costadominguezmariadelcarmen compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT navarreterodriguezelsymaureen compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT macouzetsanchezcarlos compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT ortegamartelljoseantonio compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT pozobeltrancesarfireth compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT estradacardonaalan compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT ariascruzalfredo compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT rodriguezgalvankarenguadalupe compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT britodiazherson compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT cansecoraymundomariadelrosario compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT castelanchavezenriqueemanuel compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT escalantedominguezalbertojose compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT galvezromerojoseluis compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT gomezverajavier compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT gonzalezdiazsandranora compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT guerreronunezmariagraciabelinda compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT hernandezcolindantedaniel compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT maciasweinmannalejandra compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT mendozahernandezdavidalejandro compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT menesessancheznestoralejandro compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT mogicamartinezmariadolores compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT moncayocoellocarolvivian compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT montielherrerajuanmanuel compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT ofarrilromanillospatriciamaria compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT onumatakaneernesto compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT ortegacisnerosmargarita compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT rangelgarzalorena compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT stoneaguilarhector compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT torreslozanocarlos compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT venegasmontoyaedna compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT wakidakusunokiguillermo compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT partidagaytanarmando compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT lopezgarciaaidaines compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT maciasroblesanapaola compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT ambrizmorenomariadejesus compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT azamarjacomeamyraali compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT beltrandepazclaudiayusdivia compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT caballerolopezchrystopherson compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT fernandezdecordovaaguirrejuancarlos compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT fernandezsotojoseroberto compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT lozanosaenzjosesantos compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT oyoquifloresjosejoel compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT osorioescamillarobertoefrain compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT ramirezjimenezfernando compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT riveroyeverinodaniela compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT martinezinfanteeric compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines AT medinaavalosmiguelalejandro compromisingbetweeneuropeanandusallergenimmunotherapyschoolsdiscussionsfromguimitthemexicanimmunotherapyguidelines |